
Figure 1
Synthesis of QASs derived from (1R,3S)-(+)-camphoric acid.
Table 1
Characterization of camphoric acid-derived QAS 1.
| Compound | Formula / [α]D21 (conc[g/100 mL]., solvent) | wi(calc.)/% wi(found)/% | Yield | M.p. | ||
|---|---|---|---|---|---|---|
| C | H | N | % | °C | ||
| 1a | C26H49BrN2O2/+7.99 (0.85, CHCl3) | 62.26 62.34 | 9.85 9.81 | 5.58 5.61 | 80 | 82–83.5 |
| 1b | C28H53BrN2O2/+6.75 (0.809, CHCl3) | 63.50 63.26 | 10.09 9.96 | 5.29 5.15 | 87 | 85–85.5 |
| 1c | C30H57BrN2O2/+7.2 (c = 0.799, CHCl3) | 64.61 64.36 | 10.30 9.96 | 5.02 4.85 | 84 | 95–96.8 |
| 1d | C32H61BrN2O2/+6,7d (c = 0.80, CHCl3) | 65.62 65.68 | 10.50 10.45 | 4.78 4.82 | 85 | 96.8–97.5 |
Table 2
Spectroscopic data of camphoric acid-derived QASs 1.
| Compound | Spectral data |
|---|---|
| 1a | IR,
/cm−1: 2921, 2843, 1723, 1669, 1469, 1373, 1343, 1332, 1179, 1002, 929, 823, 724 1H NMR (300 MHz, CDCl3) δ: 0.88 (t, 3H, J = 7.04 Hz), 0.95 (s, 3H), 0.99 (s, 3H), 1.20 (s, 3H), 1.26 (s, 13H), 1.37 (s, 4H), 1.77 (s, 2H, broad), 1.88–2.11 (m, 4H), 2.17–2.29 (m, 1H), 2.74 (d, 1H, J = 7.04 Hz), 3.51 (s, 6H), 3.60–3.70 (m, 4H), 4.11 (t, 2H, J = 8.21 Hz) 13C NMR (75 MHz, CDCl3) δ: 13.9; 14.1; 19.5; 21.9; 22.7; 22.8; 25.1; 26.2; 29.2; 29.3; 29.4; 29.5; 29.6 (2C); 31.9; 32.9; 34.0; 44.7; 51.7 (2C); 54.6; 56.2; 60.0; 64.1; 176.0; 178.2 |
| 1b | IR,
/cm−1: 2919, 2849, 1723, 1668, 1469, 1373, 1344, 1331, 1179, 989, 927, 822, 723 1H NMR (300 MHz, CDCl3) δ: 0.89 (t, 3H, J = 6.45 Hz), 0.96 (s, 3H), 0.99 (s, 3H), 1.21 (s, 3H), 1.27 (s, 15H), 1.38 (s, 4H), 1.74–2.12 (m, 8H), 2.19–2.33 (m, 1H), 2.76 (d, 1H, J = 6.45 Hz), 3.52 (s, 6H), 3.59–3.70 (m, 4H), 4.11 (t, 2H, J = 7.62 Hz) 13C NMR (75 MHz, CDCl3) δ: 13.9; 14.2; 19.5; 21.9; 22.7; 22.8; 25.1; 26.2; 29.3; 29.4 (2C); 29.5; 29.7 (4C); 31.9; 32.9; 34.0; 44.7; 51.8 (2C); 54.6; 56.2; 60.0; 64.1; 176.0; 178.3 |
| 1c | IR,
/cm−1: 2918, 2849, 1723, 1669, 1469, 1373, 1344, 1331, 1179, 990, 925, 820, 722 1H NMR (300 MHz, CDCl3) δ: 0.88 (t, 3H, J = 6.45 Hz), 0.95 (s, 3H), 0.99 (s, 3H), 1.20 (s, 3H), 1.25 (s, 21H), 1.37 (s, 4H), 1.77 (s, 2H, broad), 1.85–2.11 (m, 4H), 2.17–2.30 (m, 1H), 2.75 (d, 1H, J = 6.45 Hz), 3.51 (s, 6H), 3.56–3.70 (m, 4H), 4.11 (t, 2H, J = 7.62 Hz) 13C NMR (75 MHz, CDCl3) δ: 13.9; 14.1; 19.5; 21.9; 22.7; 22.8; 25.1; 26.2; 29.3; 29.4 (2C); 29.5; 29.7 (6C); 31.9; 32.9; 34.0; 44.6; 51.7 (2C); 54.5; 56.2; 60.0; 64.1; 176.0; 178.2 |
| 1d | IR,
/cm−1: 2918, 2848, 1723, 1668, 1469, 1373, 1344, 1331, 1179, 1001, 927, 820, 721 1H NMR (300 MHz, CDCl3) δ: 0.88 (t, 3H, J = 6.45 Hz), 0.95 (s, 3H), 0.99 (s, 3H), 1.20 (s, 3H), 1.25 (s, 27H), 1.37 (s, 2H), 1.77 (s, 2H, broad), 1.85–2.11 (m, 4H), 2.17–2.30 (m, 1H), 2.74 (d, 1H, J = 6.45 Hz), 3.51 (s, 6H), 3.59–3.70 (m, 4H), 4.11 (t, 2H, J = 7.04 Hz) 13C NMR (75 MHz, CDCl3) δ: 13.9; 14.1; 19.5; 21.9; 22.7; 22.8; 25.1; 26.2; 29.2; 29.4 (2C); 29.5; 29.7 (8C); 31.9; 32.9; 34.0; 44.6; 51.7 (2C); 54.5; 56.2; 60.0; 64.1; 176.0; 178.2 |
Table 3
Minimal inhibitory concentrations [μmol L−1] of prepared QAS 1.
| Compound | S. aureus CNCTC 29/58 | E. coli CNCTC 377/79N | C. albicans CCM 8186 |
|---|---|---|---|
| 1a | 6.1 | 24.3 | 12.2 |
| 1b | 0.7 | 5.8 | 0.7 |
| 1c | 0.6 | 5.5 | 0.6 |
| 1d | 324.1 | 665.8 | 324.1 |
| BAB | 26 | 260 | 26 |

Figure 2
Surface tension versus the logarithm of the aqueous molar concentration of 1a–1d at 25°C.
Table 4
CMC, g(CMC) and pC20 values of prepared QASs calculated from tensiometry measurements.
| 1a | 1b | 1c | 1d | |
|---|---|---|---|---|
| CMC [molL−1] | 5.07×10−3±0.23×10−3 | 9.13×10−4±0.98×10−4 | 0.97×10−4±0.05×10−4 | 8.09×10−6±1.13×10−6 |
| γ(CMC) [mNm−1] | 36.36 | 37.32 | 38.49 | 42.51 |
| pC20 | 3.5 | 4.1 | 5.1 | 5.5 |

Figure 3
Variation of log CMC with chain length of 1a–1d at 25°C.

Figure 4
Correlation of CMC [mmolL−1] and MIC [mmolL−1] of QASs 1a–1d for a) S. aureus; b) E. coli; c) C. albicans.